Insider trading or pure speculation?, page-33

I agree with your last comment there Dav - good advice!

However in regards to the other statements, you don't go to large pharma without first analysing your findings and then seeking advice from "experts". You wouldn't go curtain shopping before speaking to your partner first would you? I have no doubt they have had general discussion with large pharma in passing, however the real discussions with pharma will happen after reviewing their findings from the further analysis of the trial bloods/results and then discussing this with the experts.

I think the most likely purpose of this meeting is to give BIT additional information and resources on how to go to the correct 'large pharma' to help fund possibly the next stages. If it's just the same as trial-009 with a larger sample size and longer period than I believe this would be a waste of time and funds as from my understanding BIT225 is supposed to do it's job in the initial stages of treatment.

Personally I think this second little run is simply from the share holders who have reacted and spoken to their friends after receiving the newsletter in the mail as they don't check the company announcements online like we all obviously do. I doubt there is much more to it.